Merrill Downgrades Rite Aid to 'Sell'

Analyst Mark Husson says the drugstore chain's recovery story is nearly played out

Merrill Lynch downgraded Rite Aid (RAD ) to sell from neutral.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.